Home/Filings/4/A/0001128732-19-000027
4/A//SEC Filing

MERZOUKI ABDERRAZZAK 4/A

Accession 0001128732-19-000027

CIK 0001402328other

Filed

Oct 3, 8:00 PM ET

Accepted

Oct 4, 11:57 AM ET

Size

4.7 KB

Accession

0001128732-19-000027

Insider Transaction Report

Form 4/AAmended
Period: 2016-04-22
MERZOUKI ABDERRAZZAK
DirectorChief Operating Officer
Transactions
  • Award

    Common Stock

    2018-04-22$0.00/sh+12,000,000$12,00012,000,000 total

Issuer

Sunshine Biopharma, Inc

CIK 0001402328

Entity typeother

Related Parties

1
  • filerCIK 0001636418

Filing Metadata

Form type
4/A
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 11:57 AM ET
Size
4.7 KB